Daily Supplementation with Iron Increases Lipid Peroxidation in Young Women with Low Iron Stores

Abstract

The aim of this study was to determine whether women with low iron stores (plasma ferritin ≤ 20 μg/L) receiving a daily iron supplement for 8 wks at a level commonly used to treat poor iron status develop increased lipid peroxidation as measured by ethane exhalation rates and plasma malondialdehyde. The women served as their own control as pre- and post-supplementation periods were compared. Twelve women participated in the study for a 70-day period and consumed daily iron supplements (98 mg of iron as ferrous sulfate) from day 14 to day 70. Baseline blood and expired air samples were obtained on days 1 and 14; measurements during supplementation were performed on days 56 and 70, that is at 6 and 8 weeks of supplementation. Iron status improved during the iron supplementation period; biochemical indicators of lipid peroxidation also increased. After 6 wks of iron supplementation, serum ferritin almost doubled and body iron more than doubled. Hemoglobin levels increased slightly and other indicators of iron status became normal. However, plasma malondialdehyde (MDA) and breath ethane exhalation rates (BEER) increased by more than 40% between baseline and 6 wks of supplementation; these increases correlated significantly with plasma iron and ferritin levels. MDA was positively correlated with BEER. BEER increased further after 8 wks of iron supplementation. The increased indicators of lipid peroxidation with duration of supplementation and as iron status improved suggest that providing daily nearly 100 mg iron may not be a totally innocuous regimen for correcting iron depletion in women.

Get full access to this article

View all access options for this article.

References

CDC. Recommendations to prevent and control iron deficiency in the United States. Center for Disease Control and Prevention. Morb Mortal Wkly Rep 47:1–29, 1998.

INACG-WHO-UNICEF Guidelines for the use of supplements to prevent and treat iron deficiency anemia. In: Stoltzfus RJ, Dreyfus ML, Eds. Washington, DC: ILSI Press,1998.

Institute of Medicine, Dietary Reference Intakes. The Essential Guide to Nutrient Requirements. Washington, DC: National Academy Press, 2006.

Gutteridge JM, Rowley DA, Griffiths E, Halliwell B. Low-molecular-weight iron complexes and oxygen radical reactions in idiopathic haemochromatosis. Clin Sci 68:463–467, 1985.

Younes M, Eberhardt I, Lemoine R. Effect of iron overload on spontaneous and xenobiotic-induced lipid peroxidation in vivo. J Appl Toxicol 9:103–108, 1989.

de Valk B, Addicks MA, Gosriwatana I, Lu S, Hider RC, Marx JJ. Non-transferrin-bound iron is present in serum of hereditary haemochromatosis heterozygotes. Eur J Clin Invest 30:248–251, 2000.

Lund EK, Wharf SG, Fairweather-Tait SJ, Johnson IT. Oral ferrous sulfate supplements increase the free-radical-generating capacity of feces from healthy volunteers. Am J Clin Nutr 69:250–255, 1999.

Yang M, Collis CS, Kelly M, Diplock AT, Rice-Evans C. Do iron and vitamin C co-supplementation influence platelet function or LDL oxidability in helathy volunteers? Eur J Clin Nutr 53:367–374, 1999.

Tuomainen T, Nyyssonen K, Porkkala-Sarataho E, Salonen R, Baumgartner JA, Geisser P, Salonen JT. Oral supplementation with ferrous sulfate but not with non-ionic iron polymaltose comples increases the susceptibility of plasma lipoproteins to oxidation. Nutr Res 19:1121–1132, 1999.

10.

Proteggente AR, England TG, Rice-Evans CA, Halliwell B. Iron supplementation and oxidative damage to DNA in healthy individuals with high plasma ascorbate. Biochem Biophys Res Comm 288:245–251, 2001.

11.

Binkoski AE, Kris-Etherton PM, Beard JL. Iron supplementation does not affect the susceptibility of LDL to oxidative modification in women with low iron status. J Nutr 134:99–103, 2004.

12.

Galleano M, Puntarulo S. Role of antioxidants on the erythrocytes resistance to lipid peroxidation after acute iron overload in rats. Biochim Biophys Acta 1271:321–326, 1995.

13.

Kawabata T, Ogino T, Awai M. Protective effects of glutathione against lipid peroxidation in chronically iron-loaded mice. Biochim Biophys Acta 1004:89–94, 1989.

14.

Knutson MD, Walter PB, Ames BN, Viteri FE. Both iron deficiency and daily iron supplements increase lipid peroxidation in rats. J Nutr 130:621–628, 2000.

15.

Knutson MD, Lim AK, Viteri FE. A practical and reliable method for measuring ethane and pentane in expired air from humans. Free Radic Biol Med 27:560–571, 1999.

16.

Knutson MD. Studies of daily and intermittent oral iron supplements on iron status and lipid peroxidation in rats and humans. Doctoral thesis, University of California, Berkeley, 1998.

17.

Knutson MD, Handelman GJ, Viteri FE. Methods for measuring ethane and pentane in expired air from rats and humans. Free Radic Biol Med 28:514–519, 2000.

18.

Bothwell T, Charlton RW, Cook JD, Finch CA. Iron Metabolism in Man. London, Great Britain: Blackwell Scientific Publications, 1979.

19.

Yeo HC, Helbock HJ, Chyu DW, Ames BN. Assay of malondialdehyde in biological fluids by gas chromatography-mass spectrometry. Anal Biochem 220:391–396, 1994.

20.

Knutson MD, Viteri FE. Concentrating breath samples using liquid nitrogen: a reliable method for the simultaneous determination of ethane and pentane [published erratum appears in Anal Biochem 1999 May 15; 270(1):186]. Anal Biochem 242:129–135, 1996.

21.

Milman N, Rosdahl N, Lyhne N, Jørgensen T, Graudal N. Iron status in Danish women aged 35–65 years. Relation to menstruation and method of contraception. Acta Obstet Gynecol Scand 72:601–605, 1993.

22.

Lipschitz DA, Cook JD, Finch CA. A clinical evaluan index of iron stores. N Engl J Med 290:1213–1216, 1974.

23.

Brown E, Hopper J Jr, Hodges JL Jr, Bradley B, Wennesland R, Yamauchi H. Red cell, plasma, and blood volume in healthy women measured by radiochromium cell-labeling and hematocrit. J Clin Invest 41:2182–2190, 1962.

24.

Cook JD, Flowers CH, Skikne BS. The quantitative assessment of body iron. Blood 101:3359–3364, 2003.

25.

Pool GF, van Jaarsveld H. Dietary iron elevates LDL-cholesterol and decreases plasma antioxidant levels: influence of antioxidants. Res Commun Mol Pathol Pharmacol 100:139–150, 1998.

26.

Gropper SS, Kerr S, Barksdale JM. Non-anemic iron deficiency, oral iron supplementation, and oxidative damage in college-aged females. J Nutr Biochem 14:409–415, 2003.

27.

Derstine JL, Murray-Kolb LE, Yu-Poth S, Hargrove RL, Kris-Etherton PM, Beard JL. Iron status in association with cardiovascular disease risk in three controlled feeding studies. Am J Clin Nutr 77:56–62, 2003.

28.

Hutchison C, Al-Ashgar W, Liu DY, Hider RC, Powell JJ, Geissler CA. Oral ferrous sulphate leads to a marked increase in pro-oxidant nontransferrin-bound iron. Eur J Clin Invest 34:782–784, 2004.

29.

Aruoma OI, Bomford A, Polson RJ, Halliwell B. Nontransferrin-bound iron in plasma from hemochromatosis patients: effect of phlebotomy therapy. Blood 72:1416–1419, 1988.

30.

Livrea MA, Tesoriere L, Pintaudi AM, Calabrese A, Maggio A, Freisleben HJ, D’Arpa D, D’Anna R, Bongiorno A. Oxidative stress and antioxidant status in beta-thalassemia major: iron overload and depletion of lipid-soluble antioxidants. Blood 88:3608–3614, 1966.

31.

Walter PB, Fung EB, Killilea DW, Jiang Q, Hudes M, Madden J, Porter J, Evans P, Vichinsky E, Harmatz P. Oxidative stress and inflammation in iron-overloaded patients with beta-thalassaemia or sickle cell disease. Br J Haematol 135:254–63, 2006.

32.

Guteridge JM, Halliwell B. Free radicals and antioxidants in the year 2000. A historical look to the future. Ann N Y Acad Sci 899:136–147, 2000.

33.

Halliwell B, Gutteridge JM. Free Radicals in Biology and Medicine (3rd ed.). Oxford University Press, 1999. 936 pages.

34.

Ho YS, Magnenat JL, Gargano M, Cao J. The nature of antioxidant defense mechanisms; a lesson from transgenic studies. Environ Health Perspect 106 Suppl 5:1219–1228, 1998.

35.

Viteri FE, Ali F, Tujague J. Weekly iron supplementation improves and sustains nonpregnant women’s iron status as well or better than currently recommended short-term daily supplementation. J Nutr 129: 2013–2020, 1999.